Kings Point Capital Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $44K | Hold |
270
| – | – | ﹤0.01% | 357 |
|
2021
Q4 | $51K | Hold |
270
| – | – | ﹤0.01% | 369 |
|
2021
Q3 | $55K | Hold |
270
| – | – | ﹤0.01% | 332 |
|
2021
Q2 | $54K | Hold |
270
| – | – | ﹤0.01% | 329 |
|
2021
Q1 | $47K | Hold |
270
| – | – | ﹤0.01% | 326 |
|
2020
Q4 | $46K | Hold |
270
| – | – | ﹤0.01% | 324 |
|
2020
Q3 | $44K | Hold |
270
| – | – | 0.01% | 323 |
|
2020
Q2 | $44K | Hold |
270
| – | – | 0.01% | 288 |
|
2020
Q1 | $35K | Hold |
270
| – | – | 0.01% | 303 |
|
2019
Q4 | $38K | Hold |
270
| – | – | 0.01% | 335 |
|
2019
Q3 | $32K | Hold |
270
| – | – | 0.01% | 341 |
|
2019
Q2 | $35K | Hold |
270
| – | – | 0.01% | 295 |
|
2019
Q1 | $35K | Hold |
270
| – | – | 0.01% | 264 |
|
2018
Q4 | $30K | Hold |
270
| – | – | 0.01% | 271 |
|
2018
Q3 | $37K | Hold |
270
| – | – | 0.01% | 267 |
|
2018
Q2 | $32K | Hold |
270
| – | – | 0.01% | 274 |
|
2018
Q1 | $32K | Hold |
270
| – | – | 0.01% | 280 |
|
2017
Q4 | $34K | Hold |
270
| – | – | 0.01% | 267 |
|
2017
Q3 | $36K | Hold |
270
| – | – | 0.01% | 244 |
|
2017
Q2 | $34K | Hold |
270
| – | – | 0.01% | 247 |
|
2017
Q1 | $32K | Hold |
270
| – | – | 0.01% | 262 |
|
2016
Q4 | $29K | Hold |
270
| – | – | 0.01% | 235 |
|
2016
Q3 | $31K | Hold |
270
| – | – | 0.01% | 221 |
|
2016
Q2 | $28K | Buy |
+270
| New | +$28K | 0.01% | 234 |
|
2016
Q1 | – | Sell |
-270
| Closed | -$34K | – | 323 |
|
2015
Q4 | $34K | Hold |
270
| – | – | 0.01% | 246 |
|
2015
Q3 | $31K | Hold |
270
| – | – | 0.01% | 267 |
|
2015
Q2 | $36K | Hold |
270
| – | – | 0.01% | 246 |
|
2015
Q1 | $35K | Hold |
270
| – | – | 0.01% | 251 |
|
2014
Q4 | $31K | Hold |
270
| – | – | 0.01% | 246 |
|
2014
Q3 | $29K | Hold |
270
| – | – | 0.01% | 226 |
|
2014
Q2 | $26K | Hold |
270
| – | – | 0.01% | 228 |
|
2014
Q1 | $25K | Hold |
270
| – | – | 0.01% | 212 |
|
2013
Q4 | $24K | Hold |
270
| – | – | 0.01% | 209 |
|
2013
Q3 | $22K | Buy |
+270
| New | +$22K | 0.01% | 216 |
|